These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31040711)

  • 21. Mathematical Model-Based Accelerated Development of Extended-release Metformin Hydrochloride Tablet Formulation.
    Chen W; Desai D; Good D; Crison J; Timmins P; Paruchuri S; Wang J; Ha K
    AAPS PharmSciTech; 2016 Aug; 17(4):1007-13. PubMed ID: 26729531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compounding Metformin for Use in Functional Medicine.
    Desai S; Thompson T
    Int J Pharm Compd; 2023; 27(5):362-366. PubMed ID: 37816179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
    Bhansali A; Masoodi SR
    J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
    Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects.
    Darwish M; Bond M; Tracewell W; Robertson P; Yang R
    Clin Drug Investig; 2015 Jan; 35(1):13-22. PubMed ID: 25391549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients.
    Siavash M; Tabbakhian M; Sabzghabaee AM; Razavi N
    J Res Pharm Pract; 2017; 6(2):73-76. PubMed ID: 28616428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Taste and Grittiness of Riomet
    Marshall AC; Damstra M; Tuley M; Schifando EL
    Drugs R D; 2019 Mar; 19(1):57-66. PubMed ID: 30649711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eudragit NE30D based metformin/gliclazide extended release tablets: formulation, characterisation and in vitro release studies.
    Arno EA; Anand P; Bhaskar K; Ramachandran S; Saravanan M; Vinod R
    Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1495-8. PubMed ID: 12419917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
    Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
    Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed-dose combination therapy in type 2 diabetes mellitus.
    Blonde L; San Juan ZT; Bolton P
    Endocr Pract; 2014 Dec; 20(12):1322-32. PubMed ID: 25370323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
    Cho HY; Yoon H; Lim YC; Lee YB
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects.
    Khomitskaya Y; Tikhonova N; Gudkov K; Erofeeva S; Holmes V; Dayton B; Davies N; Boulton DW; Tang W
    Clin Ther; 2018 Apr; 40(4):550-561.e3. PubMed ID: 29548719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study.
    Saboo B; Reddy GC; Juneja S; Kedia AK; Manjrekar P; Rathod R;
    Indian J Endocrinol Metab; 2015; 19(1):129-35. PubMed ID: 25593840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and evaluation of bilayer tablet by using melt granulation technique for treatment of diabetes mellitus.
    Patel D; Patel A; Solanki T
    J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S37-9. PubMed ID: 23066199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical development of metformin extended-release tablets for type 2 diabetes: an overview.
    Schwartz SL; Gordi T; Hou E; Cramer M; Heritier M; Cowles VE
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1235-43. PubMed ID: 18721117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
    Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
    Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Extended-Release Oral Flexible Tablet (ER-OFT) Formulation for Pediatric and Geriatric Compliance: an Age-Appropriate Formulation.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Oct; 18(7):2394-2409. PubMed ID: 28138820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.